Oncolytics Biotech Updates GOBLET Cancer Study Data Timeline
San Diego, California, USA, October 14, 2026 Oncolytics Biotech Inc. has announced an important update on its GOBLET Phase...
Vaccines, Blood & Biologics
Genezen and Galibra Advance SSADH Deficiency Gene Therapy
Indianapolis, Indiana, and Boston, Massachusetts, United States, October 14, 2026 Genezen and Galibra Neuroscience have announced a manufacturing partnership...
Kalohexis Strengthens Drug Research With New Scientific Advisors
Northbrook, Illinois, United States, October 14, 2026 Kalohexis, Inc., a clinical-stage biotechnology company developing treatments for metabolic disorders, has...
Caris Life Sciences Showcases AI Precision Oncology Research
Irving, Texas, United States, October 14, 2026 Caris Life Sciences has announced that researchers from the company and its...
FibroBiologics Gains Australian Patent for Disc Regeneration
Houston, Texas, United States, October 14, 2026 FibroBiologics, Inc., a clinical-stage biotechnology company specializing in fibroblast-based cell therapies and...
Mighty Therapeutics Reports Barth Syndrome Pipeline Progress
Needham, Massachusetts, United States, October 14, 2026 Mighty Therapeutics Inc. has reported significant commercial, clinical and research milestones across...
Telix Advances Cancer Theranostics Across Three Major Cancers
Melbourne, Australia, and Indianapolis, Indiana, United States, October 14, 2026 Telix Pharmaceuticals Limited has announced plans to present 20...
Viking Therapeutics Launches Phase 3 Oral Obesity Drug Trials
San Diego, California, United States, October 14, 2026 Viking Therapeutics, Inc. has initiated its Phase 3 clinical development program...
Carnyx Therapeutics Unveils Oral Sleep Candidate CNYX-005
Indianapolis, Indiana, United States, October 13, 2026 Carnyx Therapeutics Ltd. has unveiled CNYX-005, an investigational oral therapeutic candidate designed...
Nuravax Reports Phase 1 Results for Alzheimer’s Vaccine
Irvine, California, United States, October 13, 2026 Nuravax, Inc. and the Institute for Molecular Medicine (IMM) have announced the...